Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
58.3%
% of BBH's 26 holdings also in BBP
23.0%
% of BBP's 65 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 13.2% | 2.1% | 2.1% |
|
BEIGENE LTD. SPONSORED ADR | 2.1% | 2.3% | 2.1% |
|
AMGEN INC | 16.4% | 2.0% | 2.0% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% | 1.8% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 12.6% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to BBP
|
AMGEN INC | 14.5% |
|
GILEAD SCIENCES INC | 11.1% |
|
VERTEX PHARMACEUTICALS INC | 10.8% |
 |
ARGENX SE ADR | 5.8% |
|
NATERA INC | 5.2% |
|
IQVIA HOLDINGS INC | 4.0% |
|
REGENERON PHARMACEUTICALS | 3.6% |
 |
ICON PLC | 3.2% |
|
ILLUMINA INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.6% |
BBH Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
HALOZYME THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
|
BRIDGEBIO PHARMA, INC. | -1.9% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
PTC THERAPEUTICS INC | -1.8% |